首页> 外文期刊>Expert opinion on biological therapy >FOXP3+ regulatory T cells as biomarkers in human malignancies.
【24h】

FOXP3+ regulatory T cells as biomarkers in human malignancies.

机译:FOXP3 +调节性T细胞是人类恶性肿瘤中的生物标志物。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Regulatory T cells (Treg) expressing the FOXP3 forkhead transcription factor maintain immunological self-tolerance and can enable tumour cells to escape immunosurveillance. OBJECTIVE: To provide an overview of studies using FOXP3 as a biomarker in human malignancies, particularly in the context of the antibodies used to detect FOXP3 protein expression, the cell populations selected for study, and the detection and scoring methodologies used. METHODS: A personal selection of studies analysing FOXP3 as a marker of Treg cells in human malignancies are discussed. RESULTS/CONCLUSION: FOXP3 is a useful marker that can be used in routine clinical practise to provide both diagnostic and prognostic information in human malignancies. However, the methods and reagents used to detect FOXP3 can have a significant effect on the robustness of experimental findings and conclusions.
机译:背景:表达FOXP3叉头转录因子的调节性T细胞(Treg)保持免疫自身耐受性,并使肿瘤细胞能够逃避免疫监视。目的:提供关于使用FOXP3作为人类恶性肿瘤生物标志物的研究的概述,尤其是在用于检测FOXP3蛋白表达的抗体,选择用于研究的细胞群体以及所使用的检测和评分方法学方面。方法:讨论了个人选择研究分析FOXP3作为人类恶性肿瘤中Treg细胞的标志物。结果/结论:FOXP3是一种有用的标志物,可用于常规临床实践中,以提供人类恶性肿瘤的诊断和预后信息。但是,用于检测FOXP3的方法和试剂可能会对实验结果和结论的鲁棒性产生重大影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号